Prematüre Retinopatisi

Year 2005, Volume: 3 Issue: 1, 24 - 28, 01.06.2005

Hilal Özkan Nilgün Köksal

Abstract

Prematüre retinopatisi ROP düflük doğum ağırlıklı ve erken doğan bebeklerde görülen retinal damarların anormal proliferasyonuna bağlı oluşan ve patogenezi tam olarak bilinmeyen bir hastalıktır. ROP çocukluk döneminde körlüğe en çok yol açan nedenlerden birisidir 1

References

• şener EC. Göz Hastalıkları. Yurdakök M, Erdem G (eds). Neonatoloji. 2.Baskı. Alp Ofset I. 2004.p.856-84.
• Terry TL. Extreme prematurity and fibroblastic overgrowth of persistant vascular sheat behind each crystalline lens. Am J Ophtalmol 1942;25:203-4.
• Owens WC, Owens EU. Rentrolental fibroplasia in premature infants: 2. Studies on the prophylaxis of the disease. The use of alpha tocopheryl acetate. Am J Ophtalmol 1949;32:1631-7.
• Arsan S. Prematüre Retinopatisi. T Klin Pediatri 2004;2:382-6.
• Phelps DL. Retinopathy of Prematurity: History, Classification, and Pat- hophysiology Neo Reviews 2001;2:153-66.
• Hunter DJ, Mukai S, Hirose T. Advanced retinopathy of prematurity. In: Albert DM, Jacobiec FA (eds). Principles and Practice of Ophthalmo- logy. Philadelphia: WB Saunders; 1994.p.782-91.
• Payne JW, Patz A. Current status of retrolental fibroplasia: the retino- pathy of prematurity. Ann Clin Res 1979;11:205-21.
• Zang W, Ito Y, Berlin E, et al. Role of hypoxia during normal retinal ves- sel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2003;44:3119-23.
• Smith LE. Pathogenesis of retinopathy of prematurity. Acta Pediatrica Suppl 2002; 91:26-8.
• Wilkinson- Berka JL, Alousis NS, Kelly DJ, et al. COX 2 inhibition and re- tinal angiogenesis in a mouse model of retinopathy of prematurity. In- vest Ophthalmol Vis Sci 2003; 44:974-9.
• Brook PC, Clark RAF, Cheresh DA. Requirement of vascular integrin Xvb3 for angiogenesis. Science 1994;264:563-71.
• Cryotherapy for Retinopathy of Prematurity Cooperative Group Multi- center trial of retinopathy of prematurity: Preliminary results. Arch Opt- halmol 1988;106:471-9.
• Arroe M, Peitersen B. Retinopathy of prematurity: review of a seven- year period in a Danish neonatal intensive care unit. Acta Paediatr 1994;83:501-5.
• Askie LM, Henderson-Smart DJ. Oxygen-saturation targets and outco- mes in extremely preterm infants. N Engl J Med 2003;349:959-67.
• Kinsey VE, Arnold HJ, Kalina RE, et al. PaO2 levels and retrolental fib- roplasia: a report of cooperative study. Pediatrics 1997;60:655-68.
• Wheatley CM, Dickinson JL, Mackey DA, Craig JE, Sale MM. Retino- pathy of prematurity: recent advances in our understanding. Archives of Disease in Childhood Fetal and Neonatal Edition 2002;87:78-82.
• Holmes JM, Zhang S, Leske DA, Lanier WL. Carbon dioxide-induced re- tinopathy in the neonatal rat. Curr Eye Res 1998;17:608-16.
• Shohat M, Reisner SH, Krikler R, et al. Retinopathy of prematurity: inci- dence and risk factors. Pediatrics 1983;72:159–63.
• Lucey JF, Dangman BA. Reexamination of the role of oxygen in retro- lental fibroplasia. Pediatrics 1984;73:82-96.
• Lin HJ, Lin CC, Tsai SW, Lin HC, Su BH. Risk factors for retinopathy of prematurity in very low birth weight infants. J Chin Med Assoc 2003;66:662-8.
• Kopylov U, Sirota L, Linder N. Retinopathy of prematurity risk factors Harefuah 2002;141:1066-9.
• Christiansen SP, Fray KJ, Spencer T. Ocular outcomes in low birth we- ight premature infants with intraventricular hemorrhage. J Pediatr Ophthalmol Strabismus 2002;39:157-65.
• Finer NN, Schindler RE, Grand G, Peters K. Effect of intramuscular vita- min E on the frequency and severity of retrolental fibroplasia: a cont- rolled trial. Lancet 1982;1:1087-8.
• Englert JA, Saunders RA, Purohit D, et al. The effect of anemia on reti- nopathy of prematurity in extremely low birth weight infants. J Perina- tol 2001;21:21–6
• Wallace DK, Kylstra JA, Phillips SJ, et al. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. JAAPOS 2000;4:343-7.
• Hammer ME, Mullen PW, Ferguson JG, Pai S, Cosby C, Jackson JK. Lo- gistic analysis of risk factors retinopathy of prematurity. Am J Ophthal 1986;102:1-6.
• Inder TE, Clement RS, Austin NC, Graham P, Darlow BA. High iron sta- tus in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 1997;131:541-4.
• Phelps DL, Watts JL. Early light reduction for preventing retinopathy of prematurity in very low birth weight infants. Cochrane Library, Issue 2, 2002.
• Reynolds JD, Hardy RJ, Kennedy KA, et al. Lack of efficacy of light re- duction in preventing retinopathy of prematurity. N Engl J Med 1998;338:1572-6.
• Msall EM, Phelps DL, DiGaudino KM, et al. On behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functi- onal outcome at age 5.5 years. Pediatrics 2000;106:998-1005.
• Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of pre- maturity.1989-1997. Pediatrics 1999;104:26-7.
• Rowlands E, Ionides AC, Chinn S, Mackinnon H, Davey CC. Reduced in- cidence of retinopathy of prematurity. Br J Ophthalmol 2001;85:933-5.
• Repha MX, Hardy RJ, Phelps DL, Gail-Summers C. Surfactant prophyla- xis and retinopathy of prematurity. Arch Opthalmol 1993;111:618-20.
• Rankin SJ, Tubman TR, Halliday HL, Johnston SS. Retinopathy of pre- maturity in surfactant treated infants. Br J Opthalmol 1992;76:202-4.
• Hack M, Wright LL, Shankaran S, et al. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Ne- onatal Network, November 1989 to October 1990. Am J Obstet Gynecol 1995;172:457-64.
• Clement R, Darlow B. Results of screening low-birth-weight infants for retinopathy of prematurity. Curr Opin Ophthalmol 1999;10:155-63.
• Higgins RD, Mandelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthamol 1998;116;601-5.
• Cosolve V, Gagliardi L, De Giorgi A, De Ponti E. Retinopathy of prematu- rity and antenatal corticosteroids. The Italian ROP Study Group. Acta Biomed Ateneo Parmense 1997;68:75-9.
• Sobel DB, Philip AG. Prolonged dexamethasone therapy reduces the in- cidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Pediat- rics 1992;90:529-33.
• Haroon Parupia MF, Dhanireddy R. Association of postnatal dexamet- hasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth- weight infants. J Perinatol 2001;21:242-7.
• Wright K, Wright SP. Lack of association of glucocorticoid therapy and retinopathy of prematurity. Arch Pediatr Adolesc Med 1994;148:848-52.
• Cuculich PS, DeLozier KA, Mellen BG, Shenai JP. Postnatal dexametha- sone treatment and retinopathy of prematurity in very-low-birth-weight neonates. Biol Neonate 2001;79:9-14.
• Seiberth V, Linderkamp O. Risk factors of retinopathy of prematurity. A multivariate statistical analysis. Ophthalmologica 2000;214:131-5.
• Hadi HA, Hobbs CL. Effect of chronic intrauterine stress on the disap- pearance of tunica vasculosa lentis of the fetal eye: a neonatal obser- vation. Am J Perinatol 1990;7:23-5.
• Bardin C, Rossignol M, Papageogiou A. A retinopathy of prematurity and intrauterine growth retardation in infants
• Mittal M, Dhanireddy R, Higgins RD. Candida sepsis and association with retinopathy of prematurity. Pediatrics 1998;101:654-7.
• Karlowictz MG, Giannone PJ, Pestian J, Morrow AL, Shults J. Does candidemia predict threshold retinopathy of prematurity in exteremly low birth weight (
• Watts P, Adams GG. In vitro fertilisation and stage 3 retinopathy of pre- maturity. Eye 2000; 14:330-3.
• Ben Sira I, Nissenkorn I, Kremer I. Retinopathy of prematurity. Surv Ophthalmol 1988;33:1-16.
• Kanski JJ. Retinopathy of Prematurity. In: Kanski JJ (eds). Clinical Opt- halmology. Oxford: Butterworth-Heinemann;1994.p.374-6.
• Ressel GW. American Academy of Pediatrics Section on Ophthalmo- logy; American Association for Pediatric Ophthalmology and Strabis- mus; American Academy of Opht halmology. AAP releases policy sta- tement on eye examinations. Am Fam Physician 2003;68:1664-6.
• Subhani M, Combs A, Weber P, Gerontis C, Joseph D. Screening Guide- lines for Retinopathy of Prematurity: The Need for Revision in Extre- mely Low Birth Weight Infants. Pediatrics 2001;107:656-9.
• McNamara JA. Retinopathy of prematurity. In: Tasman SW (eds). Clini- cal Decision in Medical Retinal Diseases. St.Louise: Mosby Year Book Inc; 1994.chapter 17.
• Siegel RA, Snir M, Cotlear D, Maayan A, Frilling R, Rosenbaltt I, Wein- berger D, Kremer I, Sirota L. Diode laser treatment of posterior retino- pathy of prematurity. Br J Ophthalmol 2000;84:1383-6.
• Banach MJ, Breinstein DM. Laser therapy for retinopathy of prematur- tiy. Curr Opin Ophthalmol 2001;12:164-70.
• Noonan CP, Clark DI. Trends in the management of stage 3 retinopaty of prematurity. Br J Ophthalmol 1996;80:278-81.
• Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of re- tinopaty of prematurity. Ophthalmology 1991; 98:1628-40.
• Cats BP, Tan KEWP. Prematures with and without regressed retino- pathy of prematurity: Comparison of long term (6-10 years) ophthalmo- logical morbidity. Pediatr Ophthalmol Strabismus 1989;26:271-5.
• Eric AP, Robert AP, Lois EHS. Retinopathy of prematurity. In: Albert DM, Jacobiec FA (eds). Principles and Practice of Ophthalmology. Philadelphia: WB Saunders; 1998.p.4443-60.
• Ueda N, Ogino N. Angle-closure glaucoma with pupillary block mec- hanism in cicatricial retinopathy of prematurity. Ophthalmologica 1988;196:15-8.